Perspective Therapeutics Inc

ASE:CATX

3.36

-0.02 (-0.59%)

7:15:08 PM EDT: $3.30 -0.06 (-1.79%)

Market Cap (Intraday)	248.05M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.2 Million
Adjusted EPS	-$0.32

See more estimates

10-Day MA	$3.53
50-Day MA	$3.79
200-Day MA	$3.35

See more pivots

Perspective Therapeutics Inc Stock, ASE:CATX

2401 Elliott Avenue, Suite 320, Seattle, Washington 98121

United States of America

Phone: +1.206.676.0900

Number of Employees: 119

http://perspectivetherapeutics.com

Description

Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers. The company was founded in 1983 and is headquartered in Seattle, WA.